β2‐adrenoreceptor medications and risk of Parkinson disease

Susan Searles Nielsen, Anat Gross, Alejandra Camacho‐Soto, Allison W. Willis, Brad A. Racette

Annals of Neurology · 2018 · 85 citations · 17 references

Abstract

β2-adrenoreceptor agonists and antagonists do not appear to alter PD risk. Ann Neurol 2018;84:691-701.

References

17